ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management Published on June 2014
Report Summary Pain is the single most common reason patients seek medical care, accounting for approximately half of all physician office visits in the United States (U.S.); some studies suggest that more than one-third of people in the U.S. suffer from a chronic pain condition at some point in their lives. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for pain management products. Product areas covered by the scope of this report include pain management pharmaceuticals (e.g., nonprescription analgesics and anesthetics including systemic and topical formulations, as well as prescription analgesics and anesthetics including prescription NSAIDs, opioid analgesics, opioid/nonopioid combination analgesics, antimigraine analgesics, adjuvant analgesics, and general/regional/local anesthetics) and pain management devices (e.g., electrical stimulators including TENS systems and neurostimulators, as well as analgesia infusion pumps including implantable and external models). During the forecast period covered by this report, the combined U.S. market for pain management products is projected to increase from $36.4 billion in 2013 to $44.7 billion in the year 2018. Pain management pharmaceuticals account for more than 92% of total sales, with pain management devices accounting for the remaining 8% of sales.
Table of Content EXECUTIVE SUMMARY i. Pain Management Pharmaceuticals a. Nonprescription Analgesics and Anesthetics i. Nonprescription Systemic Analgesics ii. Nonprescription Topical Analgesics iii. Market Forecast b. Prescription Analgesics and Anesthetics i. Prescription Non-Steroidal Anti-Inflammatory Drugs ii. Opioid Analgesics iii. Opioid/Nonopioid Combination Analgesics iv. Antimigraine Analgesics v. Adjuvant Analgesics vi. General, Regional, and Local Anesthetics vii. Market Forecast c. Combined Market Forecast ii. Pain Management Devices a. Electrical Stimulators i. Transcutaneous Electrical Nerve Stimulators ii. Neurostimulators iii. Market Forecast
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 1/8
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! b. Analgesia Infusion Pumps i. Implantable Analgesia Infusion Pumps ii. External Analgesia Infusion Pumps iii. Market Forecast c. Combined Market Forecast iii. Combined Market Forecast Exhibit ES-1: Nonprescription Analgesics/Anesthetics, Market Share, by Product Segment, 2013 and 2018 Exhibit ES-2: Prescription Analgesics/Anesthetics, Market Share, by Product Segment, 2013 and 2018 Exhibit ES-3: Pain Management Pharmaceuticals, Combined Market Share, by Product Segment, 2013 and 2018 Exhibit ES-4: Electrical Stimulators, Market Share, by Product Segment, 2013 and 2018 Exhibit ES-5: Analgesia Infusion Pumps, Market Share, by Product Segment, 2013 and 2018 Exhibit ES-6: Pain Management Devices, Combined Market Share, by Product Segment, 2013 and 2018 Exhibit ES-7: Pain Management Pharmaceuticals and Devices, Combined Market Share, by Product Segment, 2013 and 2018 1. PAIN MANAGEMENT OVERVIEW 1.1 Pain Physiology 1.1.1 The Nervous System 1.1.2 Pain Perception 1.1.3 Pain Classification 1.1.3.1 Nociceptive Pain 1.1.3.2 Non-Nociceptive Pain 1.1.3.3 Acute Pain 1.1.3.4 Chronic Pain 1.2 Pain Assessment Techniques 1.3 Pain Prevalence 1.4 Common Pain Syndromes 1.4.1 Arthritis Pain 1.4.2 Back Pain 1.4.3 Burn Pain 1.4.4 Cancer Pain 1.4.5 Headache Pain 1.4.6 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Pain 1.4.7 Obstetric Pain 1.4.8 Podiatric Pain 1.4.9 Sciatic Pain 1.4.10 Temporomandibular Pain 1.4.11 Trauma Pain 1.5 Clinical Approaches to Pain Management 1.5.1 Pain Management Guidelines 1.5.2 Pain Management Guidelines for Older Adults 1.5.3 Interventional Pain Management Guidelines 1.5.4 Pain Management Options 1.5.4.1 Pharmaceutical Options 1.5.4.2 Device-Based Options 1.5.4.3 Alternative Therapy Options
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 2/8
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Exhibit 1-1: Common Causes of Neuropathic Pain Exhibit 1-2: United States Population, by Selected Ages, 1990-2050 Exhibit 1-3: Overview of the Joint Commission's Standards for Pain Assessment and Management 2. PAIN MANAGEMENT PHARMACEUTICALS 2.1 Pharmaceutical Formulations and Drug Delivery 2.1.1 Oral Drug Delivery 2.1.2 Injection/Infusion Drug Delivery 2.1.2.1 Injection 2.1.2.1.1 Intramuscular Injection 2.1.2.1.2 Subcutaneous Injection 2.1.2.2 Infusion 2.1.2.2.1 Intravenous Infusion 2.1.2.2.2 Intraspinal Infusion 2.1.2.2.3 Intraoperative Site Infusion 2.1.3 Inhalation Drug Delivery 2.1.4 Transdermal Drug Delivery 2.1.5 Transmucosal Drug Delivery 2.1.6 Nonsteroidal Anti-Inflammatory Drugs 2.1.6.1 Heart Attack and Hypertension Risks 2.1.6.2 The Food and Drug Administration and Labeling 2.1.6.3 Naproxen Risks 2.2 The Benefits of Aspirin 2.2.1 Aspirin and Heart Attack/Stroke Prevention 2.2.2 Aspirin and Heart Failure 2.2.3 Aspirin and Cancer Prevention 2.3 Market Analysis 2.3.1 Nonprescription Analgesics and Anesthetics 2.3.1.1 Market Forecast 2.3.1.2 Nonprescription Systemic Analgesics 2.3.1.2.1 Acetaminophen 2.3.1.2.2 Nonprescription Nonsteroidal Anti-Inflammatory Drugs 2.3.1.2.3 Market Forecast 2.3.1.2.4 Competitive Analysis 2.3.1.3 Nonprescription Topical Analgesics and Anesthetics 2.3.1.3.1 Amino Amides and Esters 2.3.1.3.2 Capsaicin 2.3.1.3.3 Methyl and Trolamine Salicylates 2.3.1.3.4 Topical Patches 2.3.1.3.5 Market Forecast 2.3.1.3.6 Competitive Analysis 2.3.2 Prescription Analgesics and Anesthetics 2.3.2.1 Market Forecast 2.3.2.2 Prescription Nonsteroidal Anti-Inflammatory Drugs 2.3.2.2.1 Acetic Acid Derivatives 2.3.2.2.2 Anthranilic Acid Derivatives 2.3.2.2.3 Cyclooxygenase-2 Selective Inhibitors
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 3/8
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! 2.3.2.2.4 Enolic Acid Derivatives 2.3.2.2.5 Propionic Acid Derivatives 2.3.2.2.6 Salicylic Acid Derivatives 2.3.2.2.7 Market Forecast 2.3.2.2.8 Competitive Analysis 2.3.2.3 Opioid Analgesics 2.3.2.3.1 Buprenorphine 2.3.2.3.2 Butorphanol 2.3.2.3.3 Codeine 2.3.2.3.4 Fentanyl 2.3.2.3.5 Hydromorphone 2.3.2.3.6 Levorphanol 2.3.2.3.7 Meperidine 2.3.2.3.8 Morphine 2.3.2.3.9 Nalbuphine 2.3.2.3.10 Oxycodone 2.3.2.3.11 Oxymorphone 2.3.2.3.12 Pentazocine 2.3.2.3.13 Propoxyphene 2.3.2.3.14 Remifentanil 2.3.2.3.15 Tramadol 2.3.2.3.16 Tapentadol 2.3.2.3.17 Hydrocodone 2.3.2.3.18 Market Forecast 2.3.2.3.19 Competitive Analysis 2.3.2.4 Opioid/Nonopioid Combination Analgesics 2.3.2.4.1 Market Forecast 2.3.2.4.2 Competitive Analysis 2.3.2.5 Antimigraine Analgesics 2.3.2.5.1 Diclofenac 2.3.2.5.2 Dihydroergotamine 2.3.2.5.3 Divalproex Sodium 2.3.2.5.4 Triptans 2.3.2.5.5 Market Forecast 2.3.2.5.6 Competitive Analysis 2.3.2.6 Adjuvant Analgesics 2.3.2.6.1 Anticonvulsants 2.3.2.6.2 Antidepressants 2.3.2.6.3 Corticosteriods 2.3.2.6.4 Market Forecast 2.3.2.6.5 Competitive Analysis 2.3.2.7 General, Regional, and Local Anesthetics 2.3.2.7.1 Inhalation General Anesthetics 2.3.2.7.2 Intravenous General Anesthetics 2.3.2.7.3 Anesthetics Used in Balanced Anesthesia 2.3.2.7.4 Regional/Local Anesthetics 2.3.2.7.5 Market Forecast 2.3.2.7.6 Competitive Analysis
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 4/8
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! 2.3.3 Combined Market Forecast Exhibit 2-1: Advantages and Disadvantages of Common Drug Delivery Methods Exhibit 2-2: 2014, Selected Nonprescription Analgesics and Anesthetics Exhibit 2-3: 2014, Selected Prescription Analgesics and Anesthetics Exhibit 2-4: Nonprescription Analgesics and Anesthetics, Market Forecast 2013-2018 Exhibit 2-5: Nonprescription Systemic Analgesics, Market Forecast, 2013-2018 Exhibit 2-6: 2013, Nonprescription Systemic Analgesics Market, Share by Supplier Exhibit 2-7: Nonprescription Topical Analgesics/Anesthetics, Market Forecast, 2013-2018 Exhibit 2-8: 2013, Nonprescription Topical Analgesics/Anesthetics Market, Share by Supplier Exhibit 2-9: Prescription Analgesics and Anesthetics, Market Forecast, 2013-2018 Exhibit 2-10: Prescription Nonsteroidal Anti-Inflammatory Drugs, Market Forecast, 2013-2018 Exhibit 2-11: 2013, Prescription Nonsteroidal Anti-Inflammatory Drugs Market, Share by Supplier Exhibit 2-12: Prescription Opioid Analgesics, Market Forecast, 2013-2018 Exhibit 2-13: 2013, Prescription Opioid Analgesics Market, Share by Supplier Exhibit 2-14: Prescription Opioid/Nonopioid Combination Analgesics, Market Forecast, 2013-2018 Exhibit 2-15: Prescription Antimigraine Analgesics, Market Forecast, 2013-2018 Exhibit 2-16: 2013, Prescription Antimigraine Analgesics Market, Share by Supplier Exhibit 2-17: Prescription Adjuvant Analgesics, Market Forecast, 2013-2018 Exhibit 2-18: 2013, Prescription Adjuvant Analgesics Market, Share by Supplier Exhibit 2-19: General, Regional, and Local Anesthetics, Market Forecast, 2013-2018 Exhibit 2-20: 2013, General, Regional, and Local Anesthetics Market, Share by Supplier Exhibit 2-21: Pain Management Pharmaceuticals, Combined Market Forecast, 2013-2018 3. PAIN MANAGEMENT DEVICES 3.1 Electrical Stimulators 3.1.1 Transcutaneous Electrical Nerve Stimulators 3.1.1.1 Market Forecast 3.1.1.2 Competitive Analysis 3.1.2 Neurostimulators 3.1.2.1 Occipital Nerve Stimulation 3.1.2.2 Neuromuscular Stimulators 3.1.2.3 Spinal Cord and Peripheral Nerve Stimulators 3.1.2.4 Market Forecast 3.1.2.5 Competitive Analysis 3.2 Analgesia Infusion Pumps 3.2.1 Implantable Analgesia Infusion Pumps 3.2.1.1 Market Forecast 3.2.1.2 Competitive Analysis 3.2.2 External Analgesia Infusion Pumps 3.2.2.1 Nerve Block 3.2.2.2 Patient-Controlled Analgesia Infusion Pumps 3.2.2.3 Products 3.2.2.4 Market Forecast 3.2.2.5 Competitive Analysis 3.3 Combined Market Forecast
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 5/8
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Exhibit 3-1: Proposed Fourth Step of the World Health Organization Analgesic Ladder Exhibit 3-2: Selected Painful Conditions Appropriate for Electrical Stimulation Therapy Exhibit 3-3: Transcutaneous Electrical Nerve Stimulators, Market Forecast, 2013-2018 Exhibit 3-4: 2013, Transcutaneous Electrical Nerve Stimulators Market, Share by Supplier Exhibit 3-5: Neurostimulators, Market Forecast, 2013-2018 Exhibit 3-6: 2013, Spinal Cord Stimulators Market, Share by Supplier Exhibit 3-7: 2013, Neuromuscular Stimulators Market, Share by Supplier Exhibit 3-8: Implantable Analgesia Infusion Pumps, Market Forecast, 2013-2018 Exhibit 3-9: 2013, Implantable Analgesia Infusion Pumps Market, Share by Supplier Exhibit 3-10: External Analgesia Infusion Pumps, Market Forecast, 2013-2018 Exhibit 3-11: 2013, External Analgesia Infusion Pumps Market, Share by Supplier Exhibit 3-12: Pain Management Devices, Combined Market Forecast, 2013-2018 4. COMPANY PROFILES 4.1 AstraZeneca PLC 4.2 Baxter Healthcare, Inc./Baxter International, Inc. 4.3 Bayer HealthCare AG/Bayer AG 4.4 Boston Scientific Corporation 4.5 CareFusion Corporation 4.6 Chattem, Inc./sanofi-aventis LLC 4.7 DJO Global, Inc. 4.8 Eli Lilly and Company 4.9 Endo Pharmaceutical Holdings, Inc./Endo International PLC 4.10 GlaxoSmithKline PLC 4.11 Hospira, Inc. 4.12 International Rehabilitative Sciences, Inc., d/b/a RS Medical 4.13 Johnson & Johnson 4.14 Medtronic, Inc. 4.15 Pfizer, Inc. 4.16 Purdue Pharma LP 4.17 Teva Pharmaceutical Industries LTD APPENDIX: COMPANY LISTING
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 6/8
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 0.00
Quantity: _____
Corporate License--USD 0.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 7/8
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (From Issuu)
Page 8/8